Status:
WITHDRAWN
Neurofeedback With Real-Time fMRI for Treatment of PTSD
Lead Sponsor:
Duke University
Conditions:
PTSD
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
PTSD is a debilitating and costly condition and currently available treatment options have risks and limitations that necessitate development of novel interventions. Collectively, the functional brain...
Detailed Description
The proposed treatment is expected to reduce symptoms of PTSD particularly re-experiencing and hyperarousal symptoms. These improvements in symptoms are expected to translate into improved social and ...
Eligibility Criteria
Inclusion
- Fluent in English and capable of informed consent
- free of implanted metal objects
- 18-50 years of age
- Antidepressant sleep and anti-anxiety medication use is permitted
Exclusion
- Claustrophobia
- Neurological disorders, History of learning disability or developmental delay
- Current substance abuse or history of substance dependence
- Psychotic disorders
- Significant medical conditions
- Current suicidality or attempt within the previous year
- History of neurological injury or disease
- Pregnancy
- Major Axis 1 Psychiatric Disorders (exceptions are unipolar depression, past substance abuse, current or past nicotine dependence)
- Metal in the body
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03243149
Start Date
July 1 2022
End Date
January 1 2023
Last Update
December 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710